These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress. Mason RP; Walter MF; Jacob RF Circulation; 2004 Jun; 109(21 Suppl 1):II34-41. PubMed ID: 15173061 [TBL] [Abstract][Full Text] [Related]
7. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells. Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646 [TBL] [Abstract][Full Text] [Related]
9. [The role of HMG-CoA reductase inhibitors in regulation of the inflammatory processes]. Cecha J; Drabek G; Błazelonis A; Romanowski W; Zubelewicz-Szkodzińska B Wiad Lek; 2004; 57(5-6):255-8. PubMed ID: 15518071 [TBL] [Abstract][Full Text] [Related]
10. Statins and their role in vascular protection. Mason JC Clin Sci (Lond); 2003 Sep; 105(3):251-66. PubMed ID: 12793855 [TBL] [Abstract][Full Text] [Related]
11. [Non-lipid effects of statins: myth or fact?]. Urbauer E; Joukhadar C Wien Med Wochenschr; 2003; 153(11-12):244-9. PubMed ID: 12879632 [TBL] [Abstract][Full Text] [Related]
12. Pleiotropic effects of statins. Liao JK; Laufs U Annu Rev Pharmacol Toxicol; 2005; 45():89-118. PubMed ID: 15822172 [TBL] [Abstract][Full Text] [Related]
14. [Statins: possibly more than just lowering of the lipid level]. Visseren FL; Lansberg PJ; Erkelens DW; Kastelein JJ Ned Tijdschr Geneeskd; 2000 Feb; 144(7):316-21. PubMed ID: 10707742 [TBL] [Abstract][Full Text] [Related]
15. Statins and ischemic stroke. Liao JK Atheroscler Suppl; 2002 May; 3(1):21-5. PubMed ID: 12044582 [TBL] [Abstract][Full Text] [Related]
16. Antioxidative effects of statins. Adam O; Laufs U Arch Toxicol; 2008 Dec; 82(12):885-92. PubMed ID: 18670762 [TBL] [Abstract][Full Text] [Related]
17. Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins? Balakumar P; Kathuria S; Taneja G; Kalra S; Mahadevan N J Mol Cell Cardiol; 2012 Jan; 52(1):83-92. PubMed ID: 21968328 [TBL] [Abstract][Full Text] [Related]
18. Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability. Koh KK Cardiovasc Res; 2000 Sep; 47(4):648-57. PubMed ID: 10974215 [TBL] [Abstract][Full Text] [Related]
19. Statins and the role of nitric oxide in chronic heart failure. von Haehling S; Anker SD; Bassenge E Heart Fail Rev; 2003 Jan; 8(1):99-106. PubMed ID: 12652163 [TBL] [Abstract][Full Text] [Related]
20. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect against oxidized low-density lipoprotein-induced endothelial dysfunction. Li D; Mehta JL Endothelium; 2003; 10(1):17-21. PubMed ID: 12699073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]